Letter to Shareholders re CEO
Sep 28th, 2022Our Letter to Shareholders regarding ORIL’s CEO is available to download.
Our Letter to Shareholders regarding ORIL’s CEO is available to download.
Our Interim Financial Report for the half-year ended 31 December 2021 is now available to download.
It is with enormous sadness that we advise the death of our Founder and Director, Dr Kenneth Michael Wayte on 19th February 2022.
Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia